← Back to Search

NA

Collaborative Care for Addiction (CLARO Trial)

N/A
Waitlist Available
Led By Miriam Komaromy
Research Sponsored by RAND
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed over the previous 30 days at study entry and at 3 and 6 months after study entry
Awards & highlights

CLARO Trial Summary

This trial is testing whether a collaborative care model can help patients with both opioid use disorders and mental health disorders.

Eligible Conditions
  • Addiction
  • Opioid Use Disorder
  • Post-Traumatic Stress Disorder
  • Depression

CLARO Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed over the previous 30 days at study entry and at 3 and 6 months after study entry
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed over the previous 30 days at study entry and at 3 and 6 months after study entry for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
MOUD access
MOUD continuity of care
Major Depressive Disorder (MDD) symptoms
+1 more
Secondary outcome measures
Access to MDD and/or PTSD treatment
Alcohol use frequency
All-cause mortality
+8 more
Other outcome measures
Ability to access treatment quickly
Alcohol use severity
Clinician (care coordinator) communication
+18 more

CLARO Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Collaborative CareExperimental Treatment1 Intervention
Intervention is administered to patients in this arm. Care to be delivered via collaborative care.
Group II: ControlActive Control1 Intervention
Patients in this arm will receive enhanced usual care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Collaborative Care
2016
N/A
~1830

Who is running the clinical trial?

Providence Saint John's Health CenterUNKNOWN
1 Previous Clinical Trials
300 Total Patients Enrolled
Olive View-UCLA Education & Research InstituteOTHER
33 Previous Clinical Trials
879,114 Total Patients Enrolled
University of PittsburghOTHER
1,719 Previous Clinical Trials
16,341,441 Total Patients Enrolled

Media Library

Collaborative Care (NA) Clinical Trial Eligibility Overview. Trial Name: NCT04559893 — N/A
Addiction Research Study Groups: Collaborative Care, Control
Addiction Clinical Trial 2023: Collaborative Care Highlights & Side Effects. Trial Name: NCT04559893 — N/A
Collaborative Care (NA) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04559893 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is participation in this research experiment still open?

"Clinicaltrials.gov states that this particular medical trial is not open to participants at the present time, as it was last edited on November 17th 2022. However, there are currently 2592 other trials actively recruiting patients for involvement in their research."

Answered by AI

How widespread is the execution of this trial?

"As it stands, 6 cities are hosting this medical trial: Wofford Heights, Santa Monica and Los Angeles to name a few. Considering the potential travel requirements for partaking in these trials, we recommend selecting the closest site near you."

Answered by AI

What are the major goals of this research project?

"This clinical trial, which will assess conditions over a 30-day period at study entry and again at 3 & 6 months post-entry, seeks to increase Medication for Opioid Use Disorder (MOUD) access. Secondary objectives encompass MOUD initiation within 14 days of diagnosis via the patient's Electronic Health Record (EHR), Columbia Suicide Severity Rating Scales scores collected through interview, as well as quality care for Major Depressive Disorders evaluated by 4 psychotherapy visits or an adequate 12-week medication trial recorded in the EHR."

Answered by AI

Who else is applying?

What state do they live in?
California
New Mexico
How old are they?
18 - 65
What site did they apply to?
First Choice Community Healthcare - South Broadway Medical Center
University of New Mexico Family Health Clinic, Southeast Heights
University of New Mexico Family Health Clinic, North Valley
Other
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0

How responsive is this trial?

Average response time
  • < 2 Days
Most responsive sites:
  1. Clinica Sierra Vista - Kern River Health Center: < 48 hours
Typically responds via
Phone Call
Recent research and studies
Addiction Science & Clinical PracticeJournal
Collaboration Leading to Addiction Treatment and Recovery from Other Stresses (CLARO): Process of Adapting Collaborative Care for Co-occurring Opioid Use and Mental Disorders
Osilla, Karen Chan, Alex R. Dopp, Katherine E. Watkins, Venice Ceballos, Brian Hurley, Lisa S. Meredith, Isabel Leamon, Vanessa Jacobsohn, and Miriam Komaromy. 2022. “Collaboration Leading to Addiction Treatment and Recovery from Other Stresses (CLARO): Process of Adapting Collaborative Care for Co-occurring Opioid Use and Mental Disorders”. Addiction Science & Clinical Practice. Springer Science and Business Media LLC. doi:10.1186/s13722-022-00302-9.
clinicaltrials.govStudy
Collaboration Leading to Addiction Treatment and Recovery From Other Stresses
Katherine Watkins 2021. "Collaboration Leading to Addiction Treatment and Recovery From Other Stresses". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04559893.
~212 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top